Ascendis Pharma A/S (ASND)
253.38
+1.43
(+0.57%)
USD |
NASDAQ |
Aug 25, 16:00
253.38
0.00 (0.00%)
After-Hours: 18:05
Ascendis Pharma Shareholders Equity (Quarterly) : 1.642B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.642B |
| March 31, 2026 | 562.24M |
| December 31, 2025 | -191.23M |
| September 30, 2025 | -204.54M |
| June 30, 2025 | -220.18M |
| March 31, 2025 | -205.03M |
| December 31, 2024 | -109.46M |
| September 30, 2024 | -108.61M |
| June 30, 2024 | -344.17M |
| March 31, 2024 | -257.23M |
| December 31, 2023 | -160.94M |
| September 30, 2023 | -77.75M |
| June 30, 2023 | 70.74M |
| March 31, 2023 | 181.66M |
| December 31, 2022 | 281.06M |
| September 30, 2022 | 442.36M |
| June 30, 2022 | 635.47M |
| March 31, 2022 | 748.61M |
| December 31, 2021 | 1.005B |
| September 30, 2021 | 1.151B |
| June 30, 2021 | 815.29M |
| March 31, 2021 | 943.55M |
| December 31, 2020 | 1.026B |
| September 30, 2020 | 1.116B |
| June 30, 2020 | 535.90M |
| Date | Value |
|---|---|
| March 31, 2020 | 602.21M |
| December 31, 2019 | 670.26M |
| September 30, 2019 | 720.54M |
| June 30, 2019 | 768.78M |
| March 31, 2019 | 804.70M |
| December 31, 2018 | 320.14M |
| September 30, 2018 | 353.33M |
| June 30, 2018 | 387.89M |
| March 31, 2018 | 427.27M |
| December 31, 2017 | 224.80M |
| September 30, 2017 | 238.98M |
| June 30, 2017 | 144.24M |
| March 31, 2017 | 165.60M |
| December 31, 2016 | 186.28M |
| September 30, 2016 | 83.61M |
| June 30, 2016 | 101.00M |
| March 31, 2016 | 116.13M |
| December 31, 2015 | 130.71M |
| September 30, 2015 | 147.03M |
| June 30, 2015 | 151.23M |
| March 31, 2015 | |
| December 31, 2014 | 55.43M |
| September 30, 2014 | 3.157M |
| June 30, 2014 | 5.664M |
| March 31, 2014 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Evaxion AS | 9.531M |
| Genmab A/S | 5.957B |
| Zealand Pharma A/S | 2.753B |
| Cellectis SA | 41.07M |
| BioMarin Pharmaceutical, Inc. | 6.322B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.614B |
| Total Liabilities (Quarterly) | 971.27M |
| Debt to Equity Ratio | 0.3133 |
| Current Ratio | 2.991 |
| Net Debt Paydown Yield | 0.46% |